ENOV logo

Enovis Corporation (ENOV)

Profile

Full Name

Enovis Corporation

Ticker

NYSE: ENOV

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

May 8, 2008

Indexes

Not included

Website

https://www.enovis.com

Employees

7367

Key Details

Price

$31.93(+0.66%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.11B(+23.46% YoY)

Annual EPS

-$14.93(-2347.54% YoY)

PE ratio

-

Next earnings date

Nov 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $31.93
    ENOV price is $31.93

    30-Day Relative Volume

    0.80
    ENOV 30-day relative volume is 0.80

    Price Performance

    Price Today change

    +0.66%
    ENOV price is up +0.66% today

    Price YTD change

    -27.23%
    ENOV price is down -27.23% since January 1st

    Price 1-year change

    -26.33%
    ENOV price is down -26.33% year-on-year

    Price 3-year change

    -39.3%
    ENOV price is down -39.3% over the past 3 years

    Price Range

    Price All-time high

    $129.72
    ENOV price is currently -75.39% below its historical high of $129.72

    Price 3-year low

    $25.47
    ENOV price is currently +25.36% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.83B
    ENOV market capitalization is $1.83 billion

    Market cap 3-year change

    -35.9%
    ENOV market capitalization is down -35.9% over the past 3 years

    Market cap All-time high

    $5.32B
    ENOV market capitalization is currently -65.67% below its historical high of $5.32 billion

    Market cap sector rank

    79.87%
    ENOV market capitalization is higher than 79.87% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.34%
    ENOV shares outstanding is up +2.34% year-on-year

    Shares Outstanding 3-Year Change

    +5.6%
    ENOV shares outstanding is up +5.6% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.34
    ENOV beta is 1.34

    200-day SMA

    $36.79
    ENOV price is currently -13.21% below its 200-day simple moving average

    50-day SMA

    $29.91
    ENOV price is currently +6.76% above its 50-day simple moving average

    RSI

    57.90
    ENOV 14-day relative strength index is 57.90

    Volume

    0.80
    ENOV 30-day relative volume is 0.80

    ATR

    $1.16
    ENOV average true range is $1.16

    10-day Historical Volatility

    31.99%
    ENOV 10-day historical volatility is 31.99%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.11B
    ENOV annual revenue is $2.11 billion

    Revenue Analysts estimate

    $2.26B
    ENOV annual revenue is currently -6.55% lower than the consensus analysts' forecast

    Revenue 1-year change

    +23.46%
    ENOV annual revenue is up +23.46% year-on-year

    Revenue Sector rank

    89.35%
    ENOV annual revenue is higher than 89.35% of companies in Healthcare sector

    EPS

    EPS

    -$14.93
    ENOV annual earnings per share is -$14.93

    EPS Analysts estimate

    $3.13
    ENOV annual earnings per share is currently -577.15% lower than the consensus analysts' forecast

    EPS 1-year change

    -2347.54%
    ENOV annual earnings per share is down -2347.54% year-on-year

    EPS Sector rank

    10.25%
    ENOV annual earnings per share is higher than 10.25% of companies in Healthcare sector

    Profit

    Gross profit

    $1.18B
    ENOV annual gross profit is $1.18 billion

    Gross margin

    56.02%
    ENOV annual gross profit margin is 56.02%

    Operating profit

    -$103.43M
    ENOV annual operating income is -$103.43 million

    Operating margin

    -4.91%
    ENOV annual operating profit margin is -4.91%

    Net income

    -$827.42M
    ENOV annual net profit is -$827.42 million

    Net margin

    -39.17%
    ENOV annual net profit margin is -39.17%

    Expenses

    Total expenses

    $2.21B
    ENOV annual total expenses is $2.21 billion

    Operating expenses

    $1.28B
    ENOV annual total operating expenses is $1.28 billion

    Cost of goods sold

    $926.87M
    ENOV annual cost of goods sold is $926.87 million

    Selling, general & administrative expenses

    $1.03B
    ENOV annual SGA is $1.03 billion

    Depreciation and amortization

    $284.80M
    ENOV annual depreciation & amortization is $284.80 million

    Interest expense

    $0.00
    ENOV annual interest expense is $0.00

    Income tax

    $4.49M
    ENOV annual income tax is $4.49 million

    EBIT & EBITDA

    EBIT

    -$765.82M
    ENOV annual earnings before interest & taxes is -$765.82 million

    EBITDA

    -$481.03M
    ENOV annual EBITDA is -$481.03 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $4.72B
    ENOV annual total assets is $4.72 billion

    Non current assets

    $3.57B
    ENOV annual long term assets is $3.57 billion

    Current assets

    $1.15B
    ENOV annual total current assets is $1.15 billion

    Cash and cash equivalents

    $48.17M
    ENOV annual cash & cash equivalents is $48.17 million

    Accounts receivable

    $407.03M
    ENOV annual accounts receivable is $407.03 million

    Inventory

    $547.12M
    ENOV annual inventory is $547.12 million

    Liabilities

    Total liabilities

    $2.15B
    ENOV annual total liabilities is $2.15 billion

    Long term liabilities

    $1.63B
    ENOV annual total long term liabilities is $1.63 billion

    Current liabilities

    $529.00M
    ENOV annual total current liabilities is $529.00 million

    Accounts payable

    $179.10M
    ENOV annual accounts payable is $179.10 million

    Debt

    Total debt

    $1.40B
    ENOV annual total debt is $1.40 billion

    Total debt 1-year change

    +161.79%
    ENOV annual total debt is up +161.79% year-on-year

    Long term debt

    $1.36B
    ENOV annual long term debt is $1.36 billion

    Short term debt

    $42.37M
    ENOV annual short term debt is $42.37 million

    Equity & Capital

    Shareholders equity

    $2.56B
    ENOV annual stockholders equity is $2.56 billion

    Book value

    $2.56B
    ENOV annual book value is $2.56 billion

    Retained earnings

    -$283.02M
    ENOV annual retained earnings is -$283.02 million

    Working capital

    $617.45M
    ENOV annual working capital is $617.45 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $113.50M
    ENOV annual cash flow from operations is $113.50 million

    Cash from operations 1-year change

    -15.92%
    ENOV annual cash flow from operations is down -15.92% year-on-year

    Cash from investing

    -$955.47M
    ENOV annual cash flow from investing activities is -$955.47 million

    Cash from investing 1-year change

    -294.06%
    ENOV annual cash flow from investing activities is down -294.06% year-on-year

    Cash from financing

    $846.82M
    ENOV annual cash flow from financing activities is $846.82 million

    Cash from financing 1-year change

    +562.63%
    ENOV annual cash flow from financing activities is up +562.63% year-on-year

    CAPEX

    CAPEX

    $180.71M
    ENOV annual capital expenditures is $180.71 million

    CAPEX 1-year change

    +47.86%
    ENOV annual capital expenditures is up +47.86% year-on-year

    Free Cash Flow

    Free cash flow

    -$67.21M
    ENOV annual free cash flow is -$67.21 million

    Free cash flow 1-year change

    -626.52%
    ENOV annual free cash flow is down -626.52% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    56.02%
    ENOV annual gross profit margin is 56.02%

    Operating margin

    -4.91%
    ENOV annual operating profit margin is -4.91%

    Net margin

    -39.17%
    ENOV annual net profit margin is -39.17%

    ROA & ROE

    ROA

    -17.93%
    ENOV annual return on assets is -17.93%

    ROE

    -27.65%
    ENOV annual return on equity is -27.65%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ENOV price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ENOV price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.71
    ENOV price to book ratio is 0.71

    PB ratio Sector rank

    29.38%
    ENOV price to book ratio is higher than 29.38% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.83
    ENOV price to sales ratio is 0.83

    PS ratio Sector rank

    18.69%
    ENOV price to sales ratio is higher than 18.69% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $3.25B
    ENOV enterprise value is $3.25 billion

    Enterprise value Sector rank

    85.29%
    ENOV enterprise value is higher than 85.29% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -6.88
    ENOV EV/EBITDA is -6.88

    EV/EBITDA Sector rank

    18.37%
    ENOV EV/EBITDA is higher than 18.37% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.17
    ENOV annual current ratio is 2.17

    Quick ratio

    1.13
    ENOV annual quick ratio is 1.13

    Leverage

    Debt to equity

    0.52
    ENOV annual debt to equity ratio is 0.52

    Interest coverage ratio

    -
    ENOV annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    4
    ENOV piotroski f-score is 4

    Altman Z-Score

    0.49
    ENOV altman z-score is 0.49

    Analyst ratings

    Recent major analysts updates

    Aug 8, 25 Wells Fargo
    Overweight
    Aug 8, 25 UBS
    Buy
    Aug 8, 25 Canaccord Genuity
    Buy
    Aug 7, 25 Needham
    Buy
    Jul 8, 25 Evercore ISI Group
    Outperform
    May 14, 25 Canaccord Genuity
    Buy
    May 9, 25 Needham
    Buy
    May 9, 25 JMP Securities
    Market Outperform
    Apr 9, 25 Needham
    Buy
    Apr 2, 25 Needham
    Buy

    Institutional Ownership

    Screeners with ENOV included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Ex Dividend dates calendar
    • What is the ticker symbol for Enovis Corporation?
    • Does Enovis Corporation pay dividends?
    • What sector is Enovis Corporation in?
    • What industry is Enovis Corporation in?
    • What country is Enovis Corporation based in?
    • When did Enovis Corporation go public?
    • Is Enovis Corporation in the S&P 500?
    • Is Enovis Corporation in the NASDAQ 100?
    • Is Enovis Corporation in the Dow Jones?
    • When was Enovis Corporation's last earnings report?
    • When does Enovis Corporation report earnings?

    What is the ticker symbol for Enovis Corporation?

    The ticker symbol for Enovis Corporation is NYSE:ENOV

    Does Enovis Corporation pay dividends?

    No, Enovis Corporation does not pay dividends

    What sector is Enovis Corporation in?

    Enovis Corporation is in the Healthcare sector

    What industry is Enovis Corporation in?

    Enovis Corporation is in the Medical Devices industry

    What country is Enovis Corporation based in?

    Enovis Corporation is headquartered in United States

    When did Enovis Corporation go public?

    Enovis Corporation's initial public offering (IPO) was on May 8, 2008

    Is Enovis Corporation in the S&P 500?

    No, Enovis Corporation is not included in the S&P 500 index

    Is Enovis Corporation in the NASDAQ 100?

    No, Enovis Corporation is not included in the NASDAQ 100 index

    Is Enovis Corporation in the Dow Jones?

    No, Enovis Corporation is not included in the Dow Jones index

    When was Enovis Corporation's last earnings report?

    Enovis Corporation's most recent earnings report was on August 7, 2025

    When does Enovis Corporation report earnings?

    The next expected earnings date for Enovis Corporation is November 12, 2025
    On this page